EDAP TMS S.A. (EDAP)
- GlobeNewswire
EDAP Announces Final Results from HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy to be Presented During Plenary Session at the Upcoming 119th American Urological Association (AUA) Annual Meeting
LYON, France, April 23, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, announced that final results from the HIFI Study, the largest clinical trial ever conducted comparing EDAP’s Focal One robotic high intensity focused ultrasound (HIFU) versus radical prostatectomy (RP) for the treatment of prostate cancer, will be presented during a plenary session at the 119th American Urological Association Annual Meeting (AUA 2024), which is taking place from May 3-
- Simply Wall St.
EDAP TMS S.A. (NASDAQ:EDAP) Just Reported Earnings, And Analysts Cut Their Target Price
EDAP TMS S.A. ( NASDAQ:EDAP ) last week reported its latest yearly results, which makes it a good time for investors to...
- Insider Monkey
EDAP TMS S.A. (NASDAQ:EDAP) Q4 2023 Earnings Call Transcript
EDAP TMS S.A. (NASDAQ:EDAP) Q4 2023 Earnings Call Transcript March 27, 2024 EDAP TMS S.A. misses on earnings expectations. Reported EPS is $-0.15 EPS, expectations were $-0.04607. EDAP isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings and welcome to […]
